(Q36452474)

14 August 2017

Glycolamide esters as biolabile prodrugs of carboxylic acid agents: synthesis, stability, bioconversion, and physicochemical properties (English)

1 reference

14 August 2017

Glycolamide Esters as Biolabile Prodrugs of Carboxylic Acid Agents: Synthesis, Stability, Bioconversion, and Physicochemical Properties (English)

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

3 January 2023

main subject

pharmaceutical science

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

3 January 2023

author name string

N. M. Nielsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3379586

3 January 2023

H. Bundgaard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3379586

3 January 2023

language of work or name

English

0 references

publication date

1 April 1988

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:S0022354915476701?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

https://api.elsevier.com/content/article/PII:S0022354915476701?httpAccept=text/plain

3 January 2023

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Journal of Pharmaceutical Sciences

3 January 2023

published in

1 reference

14 August 2017

77

1 reference

14 August 2017

4

1 reference

14 August 2017

285-298

1 reference

Clinical significance of esterases in man.

14 August 2017

8

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Esterases: Problems of identification and classification

3 January 2023

9

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs

3 January 2023

11

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Nonsteroidal antiinflammatory agents. I. 6-Substituted 2-naphthylacetic acids

3 January 2023

16

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Fenbufen, a New Anti-Inflammatory Analgesic: Synthesis and Structure-Activity Relationships of Analogs

3 January 2023

17

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Esters of N,N-disubstituted 2-hydroxyacetamides as a novel highly biolabile prodrug type for carboxylic acid agents

3 January 2023

19

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Synthetic and fermentation-derived angiotensin-converting enzyme inhibitors

3 January 2023

20

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Enalapril (MK421) activation in man: importance of liver status

3 January 2023

22

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

3 January 2023

23

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Determination of pentopril, an angiotensin converting enzyme inhibitor, and its active metabolite in urine

3 January 2023

25

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats

3 January 2023

26

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite

3 January 2023

28

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

SOME NOVEL PENICILLIN DERIVATIVES

3 January 2023

29

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Studies on prodrugs of cephalosporins. I. Synthesis and biological properties of glycyloxybenzoyloxymethyl and glycylaminobenzoyloxymethyl esters of 7 beta-[2-(2- aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3- methyl-3-cephem-4-carboxylic acid

3 January 2023

31

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Preparation of 1-acyloxyethyl esters of 7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoe thy l)-1H-tetrazol-5-yl]thio]-methyl]ceph-3-em-4-carboxylic acid (cefotiam) and their oral absorption in mice

3 January 2023

34

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

The structure of urea-formaldehyde resins

3 January 2023

40

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Darstellung und Eigenschaften von Glykolid

3 January 2023

44

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

8 Kinetic analysis of progress curves

3 January 2023

46

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Simultaneous estimation ofV max, K m, and the rate of endogenous substrate production (R) from substrate depletion data

3 January 2023

47

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

MECHANISM OF ACTION OF PROTEOLYTIC ENZYMES.

3 January 2023

48

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Fitting enzyme-kinetic data to V/K.

3 January 2023

49

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

The apparent Km is a misleading kinetic indicator

3 January 2023

50

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Scientific Review No. 5. Assay of cholinesterase in clinical chemistry

3 January 2023

55

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Prediction of drug sensitivity in individuals with atypical serum cholinesterase based on in vitro biochemical studies.

3 January 2023

57

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Drug Metabolism and Disposition

3 January 2023

61

10

270

Myers

1982

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Effects of volume and surface property in hydrolysis by acetylcholinesterase. The trimethyl site

3 January 2023

62

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

THE ALPHA-CHYMOTRYPSIN-CATALYZED HYDROLYSIS OF A SERIES OF ANALOGS OF ACETYLGLYCINE METHYL ESTER.

3 January 2023

72

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Active Site of alpha-Chymotrypsin Activation by Association-Desolvation

3 January 2023

73

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.

3 January 2023

76

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Solubility and partitioning VI: octanol solubility and octanol-water partition coefficients.

3 January 2023

78

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Solubility and partitioning I: Solubility of nonelectrolytes in water.

3 January 2023

79

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

Effect of a Specific Serine Protease Inhibitor on the Rat Pancreas: Systemic Administration of Camostate and Exocrine Pancreatic Secretion

3 January 2023

84

1 reference

https://api.crossref.org/works/10.1002/JPS.2600770402

3 January 2023

Identifiers

1 reference

14 August 2017

1 reference